-
Autor
Agodi, Antonella 1 Biesiada, Grażyna 1 Brzozowski, Bartosz 1 Czepiel, Jacek 1 Deptuła, Aleksander 1 Enoch, David A 1 Fedewicz, Marcin 1 Filipczak-Bryniarska, Iwona 1 Garlicki, Aleksander 1 Goldman-Mazur, Sarah 1 Gouliouris, Theodore 1 Jurczyszyn, Artur 1 Khanafer, Nagham 1 Konturek, Katarzyna 1 Krutova, Marcela 1 Krzanowski, Marcin 1 Kuijper, Ed J 1 Michalak, Mateusz 1 Mizrahi, Assaf 1 Monpierre, Lorra 1
-
Pracoviště
Centre International de Recherche en Infecti... 1 Centre for Infectious Diseases Research Diag... 1 Clinical Microbiology and Public Health Labo... 1 Critical Care Department Vall d'Hebron Hospi... 1 Department of Gastroenterology and Hepatolog... 1 Department of Hematology Jagiellonian Univer... 1 Department of Infectious and Tropical Diseas... 1 Department of Internal and Geriatric Disease... 1 Department of Medical Microbiology Centre fo... 1 Department of Medical Microbiology Charles U... 1 Department of Medical Microbiology Medical U... 1 Department of Medical and Surgical Sciences ... 1 Department of Metabolic Diseases Jagiellonia... 1 Department of Nephrology and Dialysis Unit J... 1 Department of Pain Treatment and Palliative ... 1 Department of Propaedeutics of Medicine and ... 1 ESCMID Study Group for Clostridioides Diffic... 1 Hygienic Department Bács Kiskun County Teach... 1 Institut Micalis UMR 1319 Université Paris S... 1 Intensive Care Unit University Hospital 30 6... 1
- Formát
- Publikační typ
- Kategorie
- Jazyk
- Země
- Časopis/zdroj
- Dostupnost
- Vlastník
- Czepiel, Jacek
- Krutova, Marcela
-
Mizrahi, Assaf
Autor Mizrahi, Assaf ESCMID Study Group for Clostridioides Difficile (ESGCD), 4001 Basel, Switzerland Service de Microbiologie Clinique, Groupe Hospitalier Paris Saint-Joseph, 75014 Paris, France Institut Micalis UMR 1319, Université Paris-Saclay, INRAe, AgroParisTech, 92290 Châtenay Malabry, France
-
Khanafer, Nagham
Autor Khanafer, Nagham ESCMID Study Group for Clostridioides Difficile (ESGCD), 4001 Basel, Switzerland Unité d'Hygiène, Epidémiologie et Prévention, Groupement Hospitalier Centre, Hospices Civils de Lyon, 69002 Lyon, France Centre International de Recherche en Infectiologie (CIRI), Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases (PHE3ID), Université de Lyon, 69372 Lyon, France
- Enoch, David A
- Patyi, Márta
- Deptuła, Aleksander
- Agodi, Antonella
- Nuvials, Xavier
- Pituch, Hanna
NLK
Directory of Open Access Journals
od 2012
PubMed Central
od 2012
Europe PubMed Central
od 2012
ProQuest Central
od 2012-01-01
Open Access Digital Library
od 2012-01-01
Open Access Digital Library
od 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2012
PubMed
33805755
DOI
10.3390/antibiotics10030299
Knihovny.cz E-zdroje
We aimed to describe the clinical presentation, treatment, outcome and report on factors associated with mortality over a 90-day period in Clostridioides difficile infection (CDI). Descriptive, univariate, and multivariate regression analyses were performed on data collected in a retrospective case-control study conducted in nine hospitals from seven European countries. A total of 624 patients were included, of which 415 were deceased (cases) and 209 were still alive 90 days after a CDI diagnosis (controls). The most common antibiotics used previously in both groups were β-lactams; previous exposure to fluoroquinolones was significantly (p = 0.0004) greater in deceased patients. Multivariate logistic regression showed that the factors independently related with death during CDI were older age, inadequate CDI therapy, cachexia, malignancy, Charlson Index, long-term care, elevated white blood cell count (WBC), C-reactive protein (CRP), bacteraemia, complications, and cognitive impairment. In addition, older age, higher levels of WBC, neutrophil, CRP or creatinine, the presence of malignancy, cognitive impairment, and complications were strongly correlated with shortening the time from CDI diagnosis to death. CDI prevention should be primarily focused on hospitalised elderly people receiving antibiotics. WBC, neutrophil count, CRP, creatinine, albumin and lactate levels should be tested in every hospitalised patient treated for CDI to assess the risk of a fatal outcome.
- Publikační typ
- časopisecké články MeSH
Sdílet
Název dokumentu
Po ukončení testovacího provozu bude odkaz přesměrován adresu produkční verze portálu Medvik.